^
Association details:
| Biomarker: | PGR overexpression |
|---|---|
| Cancer: | Breast Cancer |
| Drug: | Apristor (onapristone XR) (Progesterone receptor antagonist) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Primary results of ONAWA (SOLTI-1802) trial: A window of opportunity trial of onapristone in postmenopausal women with progesterone receptor-positive/HER2-negative early breast cancer (EBC)
Published date:
10/09/2021
Excerpt:
Onapristone (ONA)...ONA XR significantly increases suppression of tumor cell proliferation in PgR-high primary breast cancer.
Trial ID:
